These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 8157758)

  • 1. Immunophenotypic characterisation of acute leukaemia after polycythemia vera.
    Hernández JM; Orfao A; González M; Cuesta B; López-Berges MC; Cañizo MC; Ciudad J; San Miguel JF
    J Clin Pathol; 1993 Jul; 46(7):668-71. PubMed ID: 8157758
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Biological properties and sensitivity to induction therapy of differentiated cells expressing atypical immunophenotype in acute leukemia of children].
    Pituch-Noworolska A
    Folia Med Cracov; 2001; 42(3):5-80. PubMed ID: 12353422
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The immunophenotype of blast transformation of chronic myelogenous leukemia: a high frequency of mixed lineage phenotype in "lymphoid" blasts and A comparison of morphologic, immunophenotypic, and molecular findings.
    Khalidi HS; Brynes RK; Medeiros LJ; Chang KL; Slovak ML; Snyder DS; Arber DA
    Mod Pathol; 1998 Dec; 11(12):1211-21. PubMed ID: 9872654
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Immunophenotype characteristics and prognosis of acute leukemia patients with cross expressing lymphoid and myeloid lineage associated antigens].
    Jiang NG; Chen XM; Zhu HL; Zhong L; Zeng TT; Jia YQ
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2010 Dec; 18(6):1405-9. PubMed ID: 21176339
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transient myeloproliferative disorder and acute myeloid leukemia in Down syndrome. An immunophenotypic analysis.
    Karandikar NJ; Aquino DB; McKenna RW; Kroft SH
    Am J Clin Pathol; 2001 Aug; 116(2):204-10. PubMed ID: 11488066
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Cellular immunophenotypes in 97 adults with acute leukemia].
    Piedras J; López-Karpovitch X; Cárdenas MR
    Rev Invest Clin; 1997; 49(6):457-64. PubMed ID: 9528305
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The immunophenotypic and clinical characteristics of NPM1 mutated acute myeloid leukemia patients].
    Liu YR; Chang Y; Ruan GR; Qin YZ; Lai YY; Shi HX; Wang YZ; Li LD; Jiang B; Li JL
    Zhonghua Xue Ye Xue Za Zhi; 2013 Feb; 34(2):98-103. PubMed ID: 23611213
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunological detection of blast cell subpopulations in acute myeloblastic leukemia at diagnosis: implications for minimal residual disease studies.
    Macedo A; Orfão A; Gonzalez M; Vidriales MB; López-Berges MC; Martínez A; San Miguel JF
    Leukemia; 1995 Jun; 9(6):993-8. PubMed ID: 7596191
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunological classification of acute myeloblastic leukemias: relevance to patient outcome.
    Casasnovas RO; Slimane FK; Garand R; Faure GC; Campos L; Deneys V; Bernier M; Falkenrodt A; Lecalvez G; Maynadié M; Béné MC
    Leukemia; 2003 Mar; 17(3):515-27. PubMed ID: 12646939
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Immunologic characteristics and prognosis of acute myeloid leukemia M1].
    Zhao F; Chen Y
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2007 Aug; 15(4):687-91. PubMed ID: 17708783
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Flow cytometric detection of residual disease in acute leukemia by assaying blasts co-expressing myeloid and lymphatic antigens.
    Syrjälä M; Anttila VJ; Ruutu T; Jansson SE
    Leukemia; 1994 Sep; 8(9):1564-70. PubMed ID: 7522295
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development of acute leukaemia after idiopathic myelofibrosis.
    Hernández JM; San Miguel JF; González M; Orfao A; Cañizo MC; Bascones C; Hernández J; López Borrasca A
    J Clin Pathol; 1992 May; 45(5):427-30. PubMed ID: 1597522
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunophenotype distinction between acute promyelocytic leukaemia and CD15- CD34- HLA-DR- acute myeloid leukaemia with nucleophosmin mutations.
    Ferrari A; Bussaglia E; Úbeda J; Facchini L; Aventin A; Sierra J; Nomdedéu JF
    Hematol Oncol; 2012 Sep; 30(3):109-14. PubMed ID: 21812014
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Correlation of immunophenotype to cytogenetics and clinical features of adult acute myeloid leukemia].
    Wang XB; Zheng JE; Gu JX; Yao JX; Yang J; Liu J; Li XQ; He YL; Yu JM; Wei J; Liu ZP; Huang SA
    Ai Zheng; 2005 Jun; 24(6):667-71. PubMed ID: 15946475
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunophenotypic characteristics of the blast crisis in chronic myeloid leukemia.
    López-Karpovitch X; Cárdenas R; Piedras J
    Rev Invest Clin; 1997; 49(1):31-6. PubMed ID: 9229753
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Flow cytometric immunophenotypic characterization of pediatric and adult minimally differentiated acute myeloid leukemia (AML-M0).
    Kotylo PK; Seo IS; Smith FO; Heerema NA; Fineberg NS; Miller K; Greene ME; Chou P; Orazi A
    Am J Clin Pathol; 2000 Feb; 113(2):193-200. PubMed ID: 10664621
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunophenotyping of acute myeloid leukaemia: relevance of analysing different lineage-associated markers.
    Lo Coco F; Pasqualetti D; Lopez M; Panzini E; Gentile A; Latagliata R; Monarca B; De Rossi G
    Blut; 1989 May; 58(5):235-40. PubMed ID: 2720173
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic value of immunophenotypic characteristics of blast cells in acute myeloid leukemia.
    Lanza F; Rigolin GM; Moretti S; Latorraca A; Castoldi G
    Leuk Lymphoma; 1994; 13 Suppl 1():81-5. PubMed ID: 7521238
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunophenotype of blast cells in acute myeloid leukemia may be a useful predictive factor for outcome.
    Tucker J; Dorey E; Gregory WM; Simpson AP; Amess JA; Lister TA; Horton MA
    Hematol Oncol; 1990; 8(1):47-58. PubMed ID: 2404842
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Surface markers in adult acute myeloblastic leukemia: correlation of CD19+, CD34+ and CD14+/DR--phenotypes with shorter survival. Groupe d'Etude Immunologique des Leucémies (GEIL).
    Solary E; Casasnovas RO; Campos L; Béné MC; Faure G; Maingon P; Falkenrodt A; Lenormand B; Genetet N
    Leukemia; 1992 May; 6(5):393-9. PubMed ID: 1375696
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.